MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 1 filers reported holding MOMENTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $17,346,000 | +216.9% | 330,524 | +100.9% | 0.01% | +175.0% |
Q2 2020 | $5,474,000 | +144.9% | 164,523 | +100.2% | 0.00% | +100.0% |
Q1 2020 | $2,235,000 | +60.1% | 82,171 | +16.2% | 0.00% | +100.0% |
Q4 2019 | $1,396,000 | +61.2% | 70,744 | +6.0% | 0.00% | 0.0% |
Q3 2019 | $866,000 | +6.8% | 66,760 | +2.5% | 0.00% | 0.0% |
Q2 2019 | $811,000 | -13.2% | 65,117 | +1.3% | 0.00% | 0.0% |
Q1 2019 | $934,000 | +70.4% | 64,312 | +29.7% | 0.00% | 0.0% |
Q4 2018 | $548,000 | -52.0% | 49,574 | +14.2% | 0.00% | 0.0% |
Q3 2018 | $1,142,000 | -17.8% | 43,415 | -36.1% | 0.00% | 0.0% |
Q2 2018 | $1,389,000 | +3.7% | 67,938 | -7.8% | 0.00% | 0.0% |
Q1 2018 | $1,339,000 | +0.6% | 73,707 | -22.8% | 0.00% | 0.0% |
Q4 2017 | $1,331,000 | -35.0% | 95,421 | -13.7% | 0.00% | -50.0% |
Q3 2017 | $2,047,000 | +44.2% | 110,596 | +31.7% | 0.00% | +100.0% |
Q2 2017 | $1,420,000 | -12.1% | 83,985 | -30.6% | 0.00% | 0.0% |
Q1 2017 | $1,616,000 | +38.7% | 121,098 | +56.4% | 0.00% | 0.0% |
Q4 2016 | $1,165,000 | +47.8% | 77,413 | +15.0% | 0.00% | 0.0% |
Q3 2016 | $788,000 | -1.6% | 67,332 | -9.2% | 0.00% | 0.0% |
Q2 2016 | $801,000 | +22.7% | 74,191 | +4.9% | 0.00% | 0.0% |
Q1 2016 | $653,000 | -34.5% | 70,696 | +5.2% | 0.00% | 0.0% |
Q4 2015 | $997,000 | +49.7% | 67,182 | +65.3% | 0.00% | 0.0% |
Q3 2015 | $666,000 | -79.2% | 40,653 | -71.0% | 0.00% | -66.7% |
Q2 2015 | $3,199,000 | +443.1% | 140,240 | +261.6% | 0.00% | +200.0% |
Q1 2015 | $589,000 | -13.3% | 38,780 | -31.2% | 0.00% | 0.0% |
Q4 2014 | $679,000 | +129.4% | 56,396 | +115.5% | 0.00% | – |
Q3 2014 | $296,000 | -95.6% | 26,169 | -95.3% | 0.00% | -100.0% |
Q2 2014 | $6,799,000 | +19.7% | 562,727 | +15.4% | 0.01% | +20.0% |
Q1 2014 | $5,681,000 | +197.9% | 487,538 | +352.1% | 0.01% | +150.0% |
Q4 2013 | $1,907,000 | -39.1% | 107,847 | -50.4% | 0.00% | -33.3% |
Q3 2013 | $3,129,000 | +130.8% | 217,462 | +141.6% | 0.00% | +200.0% |
Q2 2013 | $1,356,000 | -36.4% | 90,016 | -43.7% | 0.00% | -50.0% |
Q1 2013 | $2,132,000 | – | 159,849 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 2,790,400 | $55,055,000 | 4.79% |
Camber Capital Management LP | 3,250,000 | $64,123,000 | 3.26% |
Avidity Partners Management LP | 200,000 | $3,946,000 | 2.49% |
Asymmetry Capital Management, L.P. | 62,585 | $1,235,000 | 2.21% |
Palo Alto Investors LP | 1,685,372 | $33,252,000 | 1.83% |
Monashee Investment Management LLC | 90,223 | $1,780,000 | 1.66% |
Greencape Capital Pty Ltd | 217,078 | $4,283,000 | 1.65% |
Redmile Group, LLC | 3,237,700 | $63,880,000 | 1.53% |
Ghost Tree Capital, LLC | 400,000 | $7,892,000 | 1.50% |
Perceptive Advisors | 2,835,637 | $55,947,000 | 1.11% |